Tri-Nymyo
These highlights do not include all the information needed to use Tri-Nymyo safely and effectively. See full prescribing information forTri-Nymyo. Tri-Nymyo (norgestimate/ethinyl estradiol tablets) for oral use.Initial U.S. Approval: 1989
Approved
Approval ID
b13800f2-618f-468d-b8a5-2fc00595db61
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 8, 2022
Manufacturers
FDA
Mayne Pharma Inc.
DUNS: 867220261
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Norgestimate and Ethinyl Estradiol
PRODUCT DETAILS
NDC Product Code51862-646
Application NumberANDA090524
Marketing CategoryC73584
Route of AdministrationN/A
Effective DateJuly 6, 2020
Generic NameNorgestimate and Ethinyl Estradiol